Konstas AG - Search Results

1

Intraocular Pressure Characteristics of Exfoliative Glaucoma and Exfoliation Syndrome as Determined With the Water Drinking Test.

Mocan MC, Kasim B, Muz E, Irkec M, Orhan M, Karabulut E, Mikropoulos DG, Konstas AG. Mocan MC, et al. Among authors: konstas ag. J Glaucoma. 2016 Mar;25(3):301-5. doi: 10.1097/IJG.0000000000000223. J Glaucoma. 2016. PMID: 25642816

2

A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol.

Konstas AG, Nakos E, Tersis I, Lallos NA, Leech JN, Stewart WC. Konstas AG, et al. Am J Ophthalmol. 2002 Jun;133(6):753-7. doi: 10.1016/s0002-9394(02)01460-5. Am J Ophthalmol. 2002. PMID: 12036665 Clinical Trial.

3

Factors associated with long-term progression or stability in exfoliation glaucoma.

Konstas AG, Hollo G, Astakhov YS, Teus MA, Akopov EL, Jenkins JN, Stewart WC. Konstas AG, et al. Arch Ophthalmol. 2004 Jan;122(1):29-33. doi: 10.1001/archopht.122.1.29. Arch Ophthalmol. 2004. PMID: 14718291

4

Intraocular pressure and safety in glaucoma patients switching to latanoprost/timolol maleate fixed combination from mono- and adjunctive therapies.

Konstas AG, Bányai L, Blask KD, Väth J, Kozobolis VP, Trüb PR, Tsironi S, Maloutas S, Teus MA, Stewart WC. Konstas AG, et al. J Ocul Pharmacol Ther. 2004 Oct;20(5):375-82. doi: 10.1089/jop.2004.20.375. J Ocul Pharmacol Ther. 2004. PMID: 15650512 Clinical Trial.

5

Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.

Konstas AG, Katsimbris JM, Lallos N, Boukaras GP, Jenkins JN, Stewart WC. Konstas AG, et al. Ophthalmology. 2005 Feb;112(2):262-6. doi: 10.1016/j.ophtha.2004.08.022. Ophthalmology. 2005. PMID: 15691561 Clinical Trial.

6

24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.

Konstas AG, Karabatsas CH, Lallos N, Georgiadis N, Kotsimpou A, Stewart JA, Stewart WC. Konstas AG, et al. Ophthalmology. 2005 Apr;112(4):603-8. doi: 10.1016/j.ophtha.2004.11.032. Ophthalmology. 2005. PMID: 15808251 Clinical Trial.

7

24-hour intraocular pressure control obtained with evening- versus morning-dosed travoprost in primary open-angle glaucoma.

Konstas AG, Mikropoulos D, Kaltsos K, Jenkins JN, Stewart WC. Konstas AG, et al. Ophthalmology. 2006 Mar;113(3):446-50. doi: 10.1016/j.ophtha.2005.10.053. Ophthalmology. 2006. PMID: 16513458 Clinical Trial.

8

24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma.

Konstas AG, Topouzis F, Leliopoulou O, Pappas T, Georgiadis N, Jenkins JN, Stewart WC. Konstas AG, et al. Ophthalmology. 2006 May;113(5):761-5.e1. doi: 10.1016/j.ophtha.2006.01.029. Ophthalmology. 2006. PMID: 16650670 Clinical Trial.

9

Current concepts in the pathogenesis and management of exfoliation syndrome and exfoliative glaucoma.

Konstas AG, Tsironi S, Ritch R. Konstas AG, et al. Compr Ophthalmol Update. 2006 May-Jun;7(3):131-41. Compr Ophthalmol Update. 2006. PMID: 16882401 Review.

10

24-Hour control with a latanoprost-timolol fixed combination vs timolol alone.

Konstas AG, Lake S, Economou AI, Kaltsos K, Jenkins JN, Stewart WC. Konstas AG, et al. Arch Ophthalmol. 2006 Nov;124(11):1553-7. doi: 10.1001/archopht.124.11.1553. Arch Ophthalmol. 2006. PMID: 17102001 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters